Genomics

Dataset Information

0

Epigenetic modifiers MMSET and EZH2 physically interact and cooperate to support Multiple Myeloma pathophysiology [ChIP-seq]


ABSTRACT: Multiple myeloma (MM) is a malignant B cell dyscrasia characterized by the accumulation of clonal plasma cells (PC) within the bone marrow. Epigenetic factors are involved in MM initiation, progression, and occurrence of chemoresistance. Among them EZH2, the Polycomb Repressive Complex 2 (PRC2) catalytic subunit and NSD2 (MMSET), the target oncogene of t(4;14) primary translocation, are both associated with poor prognosis values and contribute to MM disease. In this study, we identified a physical interaction between EZH2 and MMSET in MM. We used MMSET-depleted MM cells and MAK-683, an allosteric inhibitor of EZH2, to disrupt this interaction and understand its implication in MM biology and resistance to anti-MM drugs. Through its interaction with EZH2, MMSET regulates PRC2 nuclear localization in MM cells, promotes a particularly poor prognosis in MM patients, and modulates the expression of tumor-suppressor genes involved in p53 pathway. We also demonstrated that MAK-683 can interfere with this interaction and synergizes with conventional drugs used in MM treatment: Melphalan, an alkylating agent triggering DNA Damage Response (DDR); and Panobinostat, a Histone De-Acetylase (HDAC) inhibitor directedly regulating p53 acetylation and stability.

ORGANISM(S): Homo sapiens

PROVIDER: GSE242500 | GEO | 2024/08/09

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-08-09 | GSE242451 | GEO
2023-01-25 | GSE214668 | GEO
2023-01-25 | GSE214667 | GEO
2010-10-20 | GSE24746 | GEO
2012-11-15 | E-GEOD-41651 | biostudies-arrayexpress
2010-10-20 | E-GEOD-24746 | biostudies-arrayexpress
2012-11-15 | E-GEOD-41652 | biostudies-arrayexpress
2019-01-01 | GSE98433 | GEO
2012-11-15 | GSE41652 | GEO
2012-11-15 | GSE41651 | GEO